← All stocks

Pennant Group, Inc.

PNTG No buying or selling
CIK 0001766400 #2310 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

13 insiders · 0 transactions
8.6×

Brent J. Guerisoli holds 8.6 times base salary in stock. $3.83M of shares against $444.71K in salary for 2025.

Salary from the company's own proxy. The shares are what Brent J. Guerisoli last reported holding, valued at $38.52, the price Common Stock was last bought or sold at on the open market here, on 6 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Snapper Suzanne D.
Director
230,364
$8.87M
+4.3%
Nackel John G.
Director
174,565
$6.72M
+10.3%
Gochnour John J
Chief Operating Officer
152,815
$5.89M
+23.0%
Christensen Christopher R.
Director
145,991
$5.62M
+12.6%
SMITH BARRY M
Director
102,499
$3.95M
+64.5%
Guerisoli Brent
Chief Executive Officer
99,544
$3.83M
+37.4%
Lamb Scott E
Director
58,935
$2.27M
+50.6%
COVEY STEPHEN M R
Director
44,050
$1.70M
+58.7%
Morris Gregory K Sr.
Director
37,300
$1.44M
+77.6%
Stringfield JoAnne
Director
30,275
$1.17M
+20.2%
Cheney Kirk Sterling
EVP, GC and Corp Secy
18,401
$708.84K
+43.9%
Walbom Lynette
Chief Financial Officer
16,955
$653.14K
Steik Jason Paul
Chief Clinical Officer
15,106
$581.91K
−8.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 Oct 2019